Oral Bisphosphonate Related Osteonecrosis of the Jaws: A case report.
- Author:
Jeom Sun JEONG
1
;
Ju Kang LEE
Author Information
1. Department of Rehabilitation, Gachon University of Medicine and Science, Korea. pm@gilhospital.com
- Publication Type:Case Report
- Keywords:
Osteoporosis;
Bisphosphonate;
Osteonecrosis
- MeSH:
Alendronate;
Antihypertensive Agents;
Bisphosphonate-Associated Osteonecrosis of the Jaw;
Cheek;
Curettage;
Dental Clinics;
Diphosphonates;
Female;
Heating;
Hot Temperature;
Humans;
Hypertension;
Inflammation;
Mandible;
Osteonecrosis;
Osteoporosis;
Physical Examination;
Polymethacrylic Acids;
Toothache
- From:Journal of the Korean Academy of Rehabilitation Medicine
2010;34(5):599-602
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Bisphosphonates are the most widely prescribed medications for the treatment of osteoporosis. However, bisphosphonate-related osteonecrosis of the jaw (BRONJ) is recently recognized as a serious complication among patients receiving bisphosphonate therapy. Most reports relate to BRONJ result from intravenous bisphosphonate or dental procedure. We report a case of mandible osteonecrosis related with oral bisphosphonate medication. A-63-year old woman suffered from toothache, cheek swelling and heating sense visited our dental clinic. She had taken oral alendronate and antihypertensive agents for 4 years because of osteoporosis and hypertension. Dental physical examination, radiologic study and pathologic study showed the severe inflammation and osteonecrosis of the mandible. Therefore we diagnosed the patient as having BRONJ and she stopped to take bisphosphonate and received surgical treatment with bone curettage. After surgical treatment and stopping bisphosphonate, her symptoms were improved.
